Selective mRNA Delivery to Activated Macrophages via Hyaluronic Acid-Functionalized Lipid Nanoparticles with Optimized PEGylation
Biomacromolecules · 2026
DOI: 10.1021/acs.biomac.5c02390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Mengyuan Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut Galien Paris-Saclay, UMR CNRS 8612, Université Paris-Saclay, 91400 Orsay, France. Hauptthemen laut MEDLINE: Hyaluronic Acid, Polyethylene Glycols, RNA, Messenger, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
Activated proinflammatory macrophages are associated with various inflammatory diseases, and due to their overexpression of the CD44 receptor, they may be targeted for therapy by hyaluronic acid (HA), its natural ligand. This study aimed to develop lipid nanoparticles (LNPs) functionalized with HA and stabilized with an optimized amount of poly(ethylene glycol) (PEG) for targeted mRNA delivery to activated macrophages. Using microfluidic mixing, LNPs were produced with either 1.5% PEG (LNP1.5%PEG) or 0.5% PEG (LNP0.5%PEG). HA-coated LNPs (HA-LNPs) were prepared by postinsertion of an HA-DPPE conjugate, and changes in size and zeta potential demonstrated a successful and efficient HA coating, which was quantified by spectrofluorimetry and nanoscale flow cytometry. In vitro studies showed that HA-LNP0.5%PEG exhibited better uptake in activated macrophages while maintaining mRNA transfection efficiency, whereas HA-LNP1.5%PEG did not improve its uptake, suggesting that excessive PEG can hinder targeting. Overall, HA-LNP0.5%PEG effectively delivered mRNA to activated macrophages with enhanced selectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut Galien Paris-Saclay, UMR CNRS 8612, Université Paris-Saclay, 91400 Orsay, France.
- Institut Universitaire de France (IUF), 75005 Paris, France.
- Plateforme MIPSIT-Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, UMS-IPSIT Université Paris-Saclay, US 31 INSERM, UAR 3679 CNRS, 91400 Orsay, France.
- Laboratoire NABI NAnomédecine, Biologie extracellulaire, Intégratome et Innovations, Université Paris Cité, CNRS UMR8175, INSERM U1334 75006 Paris, France.
ORCID-Profile: Séverine Domenichini, Lucile Alexandre, Hervé Hillaireau, Elias Fattal
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
Cao, M., Fay, F., Hotier, A., Domenichini, S., Alexandre, L., Ribes, C., Gazeau, F., Hillaireau, H., & Fattal, E. (2026). Selective mRNA Delivery to Activated Macrophages via Hyaluronic Acid-Functionalized Lipid Nanoparticles with Optimized PEGylation. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c02390
Vancouver
Cao M, Fay F, Hotier A, Domenichini S, Alexandre L, Ribes C, et al. Selective mRNA Delivery to Activated Macrophages via Hyaluronic Acid-Functionalized Lipid Nanoparticles with Optimized PEGylation. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c02390
BibTeX
@article{Cao2026,
author = {Cao, Mengyuan and Fay, François and Hotier, Adrouchan and Domenichini, Séverine and Alexandre, Lucile and Ribes, Christopher and Gazeau, Florence and Hillaireau, Hervé and Fattal, Elias},
title = {Selective mRNA Delivery to Activated Macrophages via Hyaluronic Acid-Functionalized Lipid Nanoparticles with Optimized PEGylation},
journal = {Biomacromolecules},
year = {2026},
doi = {10.1021/acs.biomac.5c02390}
}
EUVIMED